Pacira | PCRX - Pre Tax Profit

Stock Price
21.00
Daily Change
0.64 3.14%
Monthly
-19.23%
Yearly
-19.54%
Q1 Forecast
19.91

Pacira reported $-1.93M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.





Pre Tax Profit Change Date
Astellas Pharma JPY 133.96B 29.77B Dec/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Ligand Pharmaceuticals USD 141.14M 102M Sep/2025
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Pacira USD -1.93M 10.63M Jun/2025
Perrigo USD 22.4M 19.2M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Supernus Pharmaceuticals USD -57.95M 74.62M Sep/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025
Zoetis USD 887M 15M Sep/2025